Optimisation of recombinant human erythropoietin therapy after non-myeloablative allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Baron, F [1 ]
Vanstraelen, G [1 ]
Frere, P [1 ]
Fillet, G [1 ]
Beguin, Y [1 ]
机构：
[1] Univ Liege, B-4000 Liege, Belgium
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [1] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [2] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [3] A comparative study of non-myeloablative and myeloablative allogeneic haematopoietic stem cell transplantation in the chronic myeloid leukaemia
    Ahmed-Nacer, R
    Benakli, M
    Hamladji, RM
    Talbi, AA
    Mehdid, F
    Belhadj, R
    Pierre, KB
    Curie, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S233 - S233
  • [4] SUCCESSFUL OUTCOME AFTER NON-MYELOABLATIVE ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RENAL DYSFUNCTION
    Kersting, S.
    Verdonck, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 141 - 141
  • [5] Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation
    Schrier, RW
    Parikh, CR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) : 678 - 683
  • [6] The frequency of early complications after non-myeloablative haematopoietic stem cell transplantation
    Abdoulkadirov, K
    Golovchenko, R
    Nuyya, M
    Moiseev, S
    BONE MARROW TRANSPLANTATION, 2004, 33 : S327 - S327
  • [7] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic haematopoietic stem cell transplantation
    Plesa, A.
    Le, Q.
    Revesz, D.
    Thomas, X.
    Ducastelle, S.
    Nicolini, F. E.
    Michallet, A. S.
    Mollet, I.
    Dubois, V.
    Clark, M.
    Dumontet, C.
    Raus, N.
    Sobh, M.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S336 - S336
  • [8] Hemorrhagic toxoplasmosis after non-myeloablative condotioning therapy and allogeneic stem cell transplantation.
    Fuchs, M
    Stenzel, W
    Scheid, C
    Sasse, S
    Holtick, U
    Diehl, V
    Waldschmidt, DT
    BLOOD, 2002, 100 (11) : 438B - 438B
  • [9] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [10] Progressive disease after non-myeloablative allogeneic stem cell transplantation.
    Bolwell, BJ
    Pohlman, B
    Sobecks, R
    Andresen, S
    Theil, KS
    Brown, S
    Bernhard, L
    Curtis, J
    Koennecke, J
    Kosar, J
    Ostendorf, H
    Sands, K
    Serafin, M
    Kalaycio, M
    BLOOD, 2002, 100 (11) : 634A - 634A
12345